BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  MediciNova Announces Positive Top-Line Results from the SPRINT-MS Phase IIb Trial of MN-166 (ibudilast) in Progressive MS: Achieved Both Primary Endpoints including a Significant Reduction in Whole Brain Atrophy and Safety and Tolerability

  The study was conducted by the NeuroNEXT network with funding from the NIH National Institute of Neurological Diseases and Stroke, the National Multiple Sclerosis Society, and MediciNova.

  October 26, 2017

   · 

  9 min read
• Business

  Sonoma Pharmaceuticals Announces Fiscal Second Quarter 2018 Financial Results and Conference Call

  The earnings release will be followed by a conference call at 1:30 p.m. PST on November 9, 2017, to discuss fiscal second quarter results.

  October 26, 2017

   · 

  1 min read
• Essilor: Capital Increase Reserved for Employees Outside France

  Employee shareholding is central to Essilor’s history, identity and culture.

  October 26, 2017

   · 

  4 min read
• BioMidwest

  IDT’s 2017 Sustainability Award Funding to Exceed $50K

  Demonstrating its ongoing commitment to science advocacy and sustainability, Integrated DNA Technologies (IDT), is inviting applications for its 2017 Sustainability Award program.

  October 26, 2017

   · 

  3 min read
• Business

  K2M & Brainlab Cooperate Towards an Adapted Version of K2M Spinal Systems Compatible with Brainlab Navigation

  The two companies will collaborate in the commercial release of future navigated K2M spinal systems, which would be compatible with Brainlab spinal navigation systems.

  October 26, 2017

   · 

  9 min read
• Drug Development

  New Data Suggest Slowing of Cortical Gray Matter Atrophy with Sanofi Genzyme’s Aubagio (teriflunomide) is Associated with Delayed Conversion to Clinically Definite Multiple Sclerosis

  Sanofi Genzyme announced today new investigational data that suggest slowing of cortical gray matter volume loss (atrophy) with Aubagio (teriflunomide) is associated with delayed conversion to clinically definite multiple sclerosis.

  October 26, 2017

   · 

  9 min read
• 4WEB Medical Demonstrates Increased Subsidence Resistance for Lateral Spine Truss System Compared to Annular Implants

  4WEB Medical announced the results of a new study demonstrating reduced subsidence for its Lateral Spine Truss System as compared to annular interbody implant designs today at the annual meeting of the North American Spine Society.

  October 26, 2017

   · 

  2 min read
• Business

  CohBar to Announce Third Quarter 2017 Financial Results and Host Conference Call for Shareholders on November 13, 2017

  The company will host a conference call for the shareholders at 2:00 p.m. PT the same day.

  October 26, 2017

   · 

  2 min read
• Business

  AIT Therapeutics Strengthens Executive Team with Three Key Senior Hires as Company Prepares for Upcoming Clinical Milestones

  Joining the Company are Giora Davidai, M.D. as Chief Medical Officer, Rhona Shanker as Director of Regulatory Affairs, and Professor Asher Tal, M.D. as Senior Vice President of Clinical Research.

  October 26, 2017

   · 

  5 min read
• Business

  ReWalk Robotics to Report Third Quarter 2017 Financial Results on November 2, 2017

  ReWalk’s CEO and CFO will host a conference call to discuss the results.

  October 26, 2017

   · 

  1 min read